Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

189826 InSolution™ 5-Aza-2ʹ-Deoxycytidine - CAS 2353-33-5 - Calbiochem

189826
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
2353-33-5C₈H₁₂N₄O₄

Products

Numero di catalogoConfezionamento Qtà/conf
189826-10MG Bottiglia di vetro 10 mg
Description
OverviewA cytosine analog that acts as a DNA methyltransferase inhibitor. Restores caspase-8 and caspase-10 mRNA and protein expression as well as TRAIL (Tumor necrosis factor-Related Apoptosis Inducing Ligand) sensitivity in TRAIL-resistant cell lines. Also enhances apoptosis induced by HDAC (Histone Deacetylase) inhibitors. The solid form of this compound (Cat. No. 189825) is also available.
Catalogue Number189826
Brand Family Calbiochem®
SynonymsDecitabine
References
ReferencesEggert, A., et al. 2001. Cancer Res. 61, 1314.
Takebayashi, S., et al. 2001. Biochem. Biophys. Res. Commun. 288, 921.
Zhu, W.G., et al. 2001. Cancer Res. 61, 1327.
Hopkins-Donaldson, S., et al. 2000. Cancer Res. 60, 4315.
Haaf, T. 1995. Pharmacol. Ther. 65, 19.
Jones, P.A., and Taylor, S.M. 1980. Cell 20, 85.
Product Information
CAS number2353-33-5
FormLiquid
FormulationA 100 mM (10 mg/438 µl) solution of 5-Aza-2ʹ-Deoxycytidine (Cat. No. 189825) in DMSO.
Hill FormulaC₈H₁₂N₄O₄
Chemical formulaC₈H₁₂N₄O₄
Hygroscopic Hygroscopic
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥ 98% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Regulatory Review
Storage -20°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
189826-10MG 04055977222050

Documentation

InSolution™ 5-Aza-2ʹ-Deoxycytidine - CAS 2353-33-5 - Calbiochem MSDS

Titolo

Scheda di sicurezza (MSDS) 

InSolution™ 5-Aza-2ʹ-Deoxycytidine - CAS 2353-33-5 - Calbiochem Certificati d'Analisi

TitoloNumero di lotto
189826

Riferimenti bibliografici

Panoramica delle referenze
Eggert, A., et al. 2001. Cancer Res. 61, 1314.
Takebayashi, S., et al. 2001. Biochem. Biophys. Res. Commun. 288, 921.
Zhu, W.G., et al. 2001. Cancer Res. 61, 1327.
Hopkins-Donaldson, S., et al. 2000. Cancer Res. 60, 4315.
Haaf, T. 1995. Pharmacol. Ther. 65, 19.
Jones, P.A., and Taylor, S.M. 1980. Cell 20, 85.

Informazioni tecniche

Titolo
White Paper - The Message in the Marks: Deciphering Cancer Epigenetics
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision08-June-2012 JSW
SynonymsDecitabine
DescriptionA cytosine analog that acts as a DNA methyltransferase inhibitor. Restores caspase-8 and caspase-10 mRNA and protein expression as well as TRAIL (Tumor necrosis factor-Related Apoptosis Inducing Ligand) sensitivity in TRAIL-resistant cell lines. Also enhances apoptosis induced by HDAC (Histone Deacetylase) inhibitors. The solid form of this compound (Cat. No. 189825) is also available.
FormLiquid
FormulationA 100 mM (10 mg/438 µl) solution of 5-Aza-2ʹ-Deoxycytidine (Cat. No. 189825) in DMSO.
Intert gas (Yes/No) Packaged under inert gas
CAS number2353-33-5
Chemical formulaC₈H₁₂N₄O₄
Structure formulaStructure formula
Purity≥ 98% by HPLC
Storage Protect from light
-20°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Toxicity Regulatory Review
ReferencesEggert, A., et al. 2001. Cancer Res. 61, 1314.
Takebayashi, S., et al. 2001. Biochem. Biophys. Res. Commun. 288, 921.
Zhu, W.G., et al. 2001. Cancer Res. 61, 1327.
Hopkins-Donaldson, S., et al. 2000. Cancer Res. 60, 4315.
Haaf, T. 1995. Pharmacol. Ther. 65, 19.
Jones, P.A., and Taylor, S.M. 1980. Cell 20, 85.